TuHURA Biosciences (HURA) Accumulated Depreciation (2021 - 2026)
TuHURA Biosciences (HURA) posted quarterly Accumulated Depreciation of $2.2 million for Q1 2026, up 3.84% year-over-year from $2.1 million in Q1 2025, and up 1.09% quarter-over-quarter from $2.2 million in Q4 2025.
TuHURA Biosciences (HURA) Accumulated Depreciation (2021 - 2026) Analysis & Trends
TuHURA Biosciences' Accumulated Depreciation history runs 5 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Accumulated Depreciation rose 3.84% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (up 3.84% YoY), while the FY2025 annual figure was $2.2 million, up 3.41% from the prior year.
- Accumulated Depreciation for Q1 2026 stood at $2.2 million, up from $2.2 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $2.2 million in Q1 2026, with the low at $2.0 million in Q4 2023.
- The 4-year median for Accumulated Depreciation is $2.1 million (2025), against an average of $2.1 million.
- The sharpest annual moves came in 2024 and 2025: Accumulated Depreciation climbed 5.92% in 2024, then advanced 3.41% in 2025.
- TuHURA Biosciences' Accumulated Depreciation stood at $2.0 million in 2023, then gained by 5.92% to $2.1 million in 2024, then grew by 3.41% to $2.2 million in 2025, then rose by 1.09% to $2.2 million in 2026.
- Business Quant data shows HURA's Accumulated Depreciation at $2.2 million in Q1 2026, $2.2 million in Q4 2025, and $2.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Mar 31, 2021 | 15,000.00 |